Last reviewed · How we verify
Homeopathy
Homeopathy is a Small molecule drug developed by NMP Medical Research Institute. It is currently in Phase 1 development.
-
Baseline phase 1 → approval rate
+9.6pp
Industry-wide phase 1 drugs reach approval ~9.6% of the time (BIO/Informa 2023 industry benchmark across all therapeutic areas).
| Regulator | Country | Likely year | Lag vs FDA |
|---|---|---|---|
| FDA | US | 2033–2036 | — |
| EMA | EU | 2034–2037 | +0.7 yr |
| MHRA | GB | 2034–2037 | +0.7 yr |
| Health Canada | CA | 2034–2038 | +0.9 yr |
| TGA | AU | 2034–2038 | +1.2 yr |
| PMDA | JP | 2034–2038 | +1.5 yr |
| NMPA | CN | 2035–2039 | +2.3 yr |
| MFDS | KR | 2034–2038 | +1.4 yr |
| CDSCO | IN | 2034–2039 | +1.8 yr |
| ANVISA | BR | 2035–2039 | +2.3 yr |
Hover any row for the lag rationale. Lag estimates are reduced when the drug has FDA Breakthrough or EMA PRIME designation (sponsors file globally in parallel).
Estimate based on the BIO/Informa industry phase transition rates plus per-drug modifiers for therapeutic area, sponsor type, FDA designations, mechanism, and trial design. Per-jurisdiction lags from Tufts CSDD international approval studies. Not investment, clinical or regulatory advice. Methodology: /methodology#likelihood.
At a glance
| Generic name | Homeopathy |
|---|---|
| Sponsor | NMP Medical Research Institute |
| Modality | Small molecule |
| Therapeutic area | Other |
| Phase | Phase 1 |
Approved indications
Common side effects
Key clinical trials
- Efficacy of Arnica Montana in Reducing Postoperative Edema and Pain
- Vaginal Care System for Menopausal Women With Urinary Tract Infections (NA)
- Pilot RCT Using Homeopathic Medicines in ASD (PHASE4)
- Observational Case Series of Patients With Parkinson's Disease (PD) Attending a Complementary Medicine Neuro-degenerative Disease (NDD) Clinic.
- Feasibility of Integrating Homeopathic Approach in a Comprehensive Cancer Center
- Pilot-RCT With Individualized Homeopathic Treatment in the Children With Autism Spectrum Disorder (PHASE4)
- Flourish Vaginal Care System to Establish Neovaginal Microbiome (NA)
- Effects of Flourish HEC and BioGenesis to Improve Conception (PHASE1)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Homeopathy CI brief — competitive landscape report
- Homeopathy updates RSS · CI watch RSS
- NMP Medical Research Institute portfolio CI
Frequently asked questions about Homeopathy
What is Homeopathy?
Who makes Homeopathy?
What development phase is Homeopathy in?
Related
- Manufacturer: NMP Medical Research Institute — full pipeline
- Therapeutic area: All drugs in Other
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing